新闻
IBA celebrates a new milestone with the sale of the 100th Cyclone® KIUBE cyclotron
Wednesday, December 20th, 2023 Louvain-la-Neuve, Belgium, December 20, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in […]
查看更多WEBINAR | Will the approval of one or more AD drug unleash the use of amyloid PET imaging?
Listen the webinar on demand and be part of the forefront of PET imaging in Alzheimer's disease This interesting webinar […]
查看更多Successful rigging of IBA's Cyclone® 30XP at POLATOM, Poland
We are happy to announce the successful rigging of our Cyclone® 30XP cyclotron at POLATOM that marks a significant milestone […]
查看更多IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease
Wednesday, December 13rd, 2023 Louvain-la-Neuve, Belgium, December 13, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), CMI Inc. and Life […]
查看更多IBA pioneers theranostic advancements, empowering the market to produce Astatine-211
Tuesday, December 12th, 2023 Rigging of the Cyclone® 30XP in Poland completed with a further two sites in Germany and […]
查看更多Register for the learn & Talk session at SNMMI
Discover IBA's Learn and Talk sessions at SNMMI: Advantages and Disadvantages of 225Ac-PSMA therapy in Prostate Cancer Patients Prof. Sathkege […]
查看更多IBA Launches AKURACY®, an Integrated Solution for Cardiac PET Imaging at EACVI Meeting in Barcelona
The IBA Akuracy® is an innovative user-friendly solution designed for the automated production of 13N-ammonia used for cardiac imaging. Louvain-la-Neuve, […]
查看更多Have you already seen a flying Cyclotron?
We are proud to announce that a new Cyclone® KIUBE was rigged in Pretoria, South Africa, at Steve Biko Academic […]
查看更多IBA Reports Full Year 2022 Results
ALL-TIME RECORD ORDER INTAKE AND BACKLOG IBA ANNOUNCES MID-TERM GUIDANCE Louvain-la-Neuve, Belgium, 23 March 2023 - IBA (Ion Beam Applications […]
查看更多